Hong Kong Children's Hospital
🇭🇰Hong Kong, China
- Country
- 🇭🇰Hong Kong, China
- Ownership
- Private, Subsidiary
- Established
- 2018-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.hkch.org.hk
Clinical Trials
11
Active:0
Completed:2
Trial Phases
3 Phases
Phase 2:2
Phase 4:1
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (57.1%)Phase 2
2 (28.6%)Phase 4
1 (14.3%)Immersive Virtual Reality Exposure for Reducing Perioperative Anxiety in Children
Not Applicable
Completed
- Conditions
- Anxiety StateSatisfactionCompliance
- First Posted Date
- 2025-06-13
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- Hong Kong Children's Hospital
- Target Recruit Count
- 96
- Registration Number
- NCT07018999
- Locations
- 🇭🇰
Operating Theatre, Hong Kong Children's Hospital, Hong Kong, Hong Kong
CD-19 CAR-T Cell for Pediatric ALL or Lymphoma
Not Applicable
Recruiting
- Conditions
- Lymphoma, B-CellAcute Lymphoblastic Leukemia, Pediatric
- Interventions
- Biological: CAR-T
- First Posted Date
- 2025-03-10
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- Hong Kong Children's Hospital
- Target Recruit Count
- 18
- Registration Number
- NCT06866873
- Locations
- 🇭🇰
Hong Kong Children's Hospital, Hong Kong, Hong Kong
Total Lymphoid Irradiation as Conditioning for Pediatric Haploidentical Hematopoietic Stem Cell Transplantation
Not Applicable
Recruiting
- Conditions
- Hematopoietic Organs; Disorder
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Hong Kong Children's Hospital
- Target Recruit Count
- 23
- Registration Number
- NCT06075563
- Locations
- 🇭🇰
Hong Kong Children's Hospital, Hong Kong, Hong Kong
CD62L Depleted Donor Lymphocyte Infusion With T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation
Phase 2
Recruiting
- Conditions
- Hematopoietic Organs; Disorder
- First Posted Date
- 2023-09-13
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Hong Kong Children's Hospital
- Target Recruit Count
- 23
- Registration Number
- NCT06034535
- Locations
- 🇭🇰
Hong Kong Children's Hospital, Hong Kong, Hong Kong
Quadruple Immunotherapy for Neuroblastoma
Phase 2
Recruiting
- Conditions
- Neuroblastoma Recurrent
- Interventions
- Drug: Granulocyte-Macrophage Colony-Stimulating Factor
- First Posted Date
- 2023-03-06
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- Hong Kong Children's Hospital
- Target Recruit Count
- 29
- Registration Number
- NCT05754684
- Locations
- 🇭🇰
Hong Kong Children's Hospital, Hong Kong, Hong Kong
- Prev
- 1
- 2
- 3
- Next
News
No news found